Bumetanide Injection, Solution
Product Images NDC 83854-007

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 83854-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anthea Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Spl Carton Label Bumetanide)

Box packaging label for Bumetanide Injection, USP 1 mg/4 mL (0.25 mg/mL) injection solution. The label indicates use for intravenous or intramuscular administration and states the product contains benzyl alcohol. The box holds 10 single-dose vials, each containing 4 mL. Labeler is Anthea Pharma Private Limited.*

FDA Label Image

"image Description" (Spl Container Label Bumetanide)

Bumetanide Injection, USP label shows 1 mg/4 mL (0.25 mg/mL) injection solution for intravenous or intramuscular use. The vial contains benzyl alcohol as a preservative and is a 4 mL single-dose vial. Manufactured by Anthea Pharma Private Limited, Hyderabad, India. Storage instructions and lot/expiry placeholders are visible.*

FDA Label Image

"image Description" (Spl Structure Bumetanide)

Chemical structure of bumetanide, showing a benzene ring with attached functional groups including a carboxyl group, sulfonamide group, ethoxy group, and a butanamine side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.